全球凝血分析仪市场规模：地区、范围和预测

凝血分析仪市场规模及预测

2024年凝血分析仪市场规模预计为40.7亿美元，预计2024年至2031年复合年增长率为5.90%，到2031年预计将达到64.3亿美元。凝血分析仪是一种评估血液凝固能力的特殊医疗设备，对于识别和治疗涉及异常出血或凝血的疾病至关重要。其他活动评估各种凝血参数，例如凝血酶原时间 (PT)、活化部分凝血活酶时间 (aPTT) 和纤维蛋白原水平。这项发现将有助于医疗保健提供者监测服用抗凝血剂的患者、诊断血友病等凝血障碍以及管理深部静脉栓塞和肺栓塞等疾病。透过提供准确和及时的数据，这些技术有助于确保有效和安全的患者护理。

由于技术的改进和个人化治疗需求的增加，凝血分析仪前景光明。现场护理测试、与电子健康记录的整合以及家庭使用的小型化预计将提高凝血测试的简单性和准确性。

此外，开发能够进行详细检查和即时监测的更复杂的分析仪将改善患者的治疗结果并简化临床操作。随着医疗保健产业的发展，这些分析仪对于凝血障碍的治疗和精准医学的进步将变得至关重要。

世界凝血分析仪市场动态

塑造全球凝血分析仪市场的关键市场动态

主要市场驱动因子

血液疾病盛行率增加：

血液疾病盛行率不断上升：由于患者血液疾病盛行率不断上升，对凝血分析仪的需求量很大。根据世界血友病联合会2019年度全球调查显示，全球血友病患者超过32.4万人，比前一年增加7%。

老年人口成长：

随着世界人口老化，心血管疾病和凝血障碍的风险增加，增加了对凝血测试的需求。根据联合国《2019年世界人口展望》报告，到2050年，全球六分之一的人将超过65岁，而2019年这一比例为十分之一。

外科手术的增加：

随着全球外科手术的增加，需要在术前和术后护理中进行更多的凝血测试。根据《柳叶刀》2021 年发表的报告，2008 年至 2018 年间，全球进行的外科手术数量增加了 38.2%，每年达到 3.13 亿例。

凝血分析仪的技术进步：

凝血分析仪的技术进步，例如更高的准确性和更快的结果，正在推动市场扩张。根据美国国立卫生研究院 (NIH) 2022 年的报告，典型的实验室程序需要 30 到 60 分钟，而护理点凝血测试设备现在只需大约 1 到 3 分钟即可得出结果。

主要问题

技术复杂性：

凝血分析仪是复杂的设备，需要先进的技术和精密的工程。在保持准确性和可靠性的同时跟上技术的快速进步可能很困难。为了保持竞争力，製造商必须不断创新和升级其系统，这需要大量的研发成本。

资料管理：

现代凝血分析仪会产生大量数据，必须仔细记录、储存和处理这些数据。有效的数据管理系统对于确保结果可靠且易于存取至关重要。将这些技术与其他医院资讯系统整合可能很困难。

产品校准与维护：

需要定期校准和维护，以确保凝血分析仪的准确性和可靠性。对于资源有限的医疗机构来说，这种持续的需求尤其具有课题性，并且可能会影响营运效率和采用这些设备的成本。

成本高：

凝血分析仪的购买和维护费用昂贵。这包括设备、消耗品以及定期校准和维护需求。对于小型诊所和实验室来说，如此高的价格令人望而却步，并限制了先进凝血诊断的取得。

主要趋势

即时侦测

凝血的即时 (POC) 测试变得越来越受欢迎，因为它们可以在现场快速提供结果，而不是将样本送到中心实验室。这一趋势是由对更快的诊断结果和提高患者便利性的渴望所推动的。 POC 设备变得越来越小且更易于使用，从而能够在各种临床环境（包括急诊和门诊）中更快地做出决策。

与电子健康记录 (EHR) 整合：

凝血分析仪越来越多地与电子健康记录 (EHR) 集成，以加快数据管理并改善患者护理。该介面提供流畅的数据传输、即时存取患者资讯以及改善医疗保健提供者之间的协作，从而提高凝血测试和管理的整体效率。

紧凑性与便携性：

小型化、携带式凝血分析仪的发展是一大趋势。这些小型设备用途广泛且方便，可以在各种环境下进行凝血测试，包括偏远地区和家庭护理。便携式分析仪满足了对分散式测试解决方案不断增长的需求。

先进技术与自动化：

由于自动化和技术的进步，凝血分析仪变得越来越有用。自动化样品处理、数据处理和结果报告等功能变得越来越普遍，提高了准确性、消除了人为错误并提高了测试吞吐量。

目录

第1章简介

• 市场定义
• 市场区隔
• 调查方法

第 2 章执行摘要

• 主要发现
• 市场概览
• 市场亮点

第3章市场概述

• 市场规模与成长潜力
• 市场趋势
• 市场推动因素
• 市场阻碍因素
• 市场机会
• 波特五力分析

第 4 章凝血分析仪市场：依分析仪类型

• 临床测试分析仪
• 即时护理 (POC) 分析仪

第5章凝血分析仪市场：依应用划分

• 定期凝血测试
• 特殊凝血试验
• 血栓测试
• 其他应用

第 6 章凝血分析仪市场：依最终使用者划分

• 医院
• 诊所和医生办公室
• 诊断中心
• 研究院

第7章区域分析

• 北美
• 美国
• 加拿大
• 墨西哥
• 欧洲
• 英国
• 德国
• 法国
• 义大利
• 亚太地区
• 中国
• 日本
• 印度
• 澳大利亚
• 拉丁美洲
• 巴西
• 阿根廷
• 智利
• 中东/非洲
• 南非
• 沙乌地阿拉伯
• 阿拉伯联合大公国

第 8 章市场动态

• 市场推动因素
• 市场阻碍因素
• 市场机会
• 新冠肺炎 (COVID-19) 对市场的影响

第9章竞争态势

• 主要公司
• 市占率分析

第10章公司简介

• Abbott Laboratories
• Danaher Corporation
• Siemens Healthineers AG
• Sysmex Corporation
• Thermo Fisher Scientific Inc.
• Maccura Biotechnology Co. Ltd.
• Diagnostica Stago SAS
• Helena Laboratories

第 11 章市场前景与机会

• 新兴技术
• 未来市场趋势
• 投资机会

第12章附录

• 缩写列表
• 来源与参考文献

Blood Coagulation Analyzer Market Size And Forecast

Blood Coagulation Analyzer Market size was valued at USD 4.07 Billion in 2024 and is projected to reach USD 6.43 Billion by 2031 , growing at a CAGR of 5.90% from 2024 to 2031. A blood coagulation analyzer is a specialized medical instrument that evaluates the blood's ability to clot, which is critical in identifying and treating disorders involving irregular bleeding or clotting. These analyzers assess a variety of coagulation parameters, including prothrombin time (PT), activated partial thromboplastin time (aPTT), and fibrinogen levels, among others. The findings assist healthcare providers in monitoring patients undergoing anticoagulant medication, diagnosing clotting diseases such as hemophilia, and managing illnesses such as deep vein thrombosis and pulmonary emboli. By providing precise and timely data, these technologies help to ensure effective and safe patient care.

The blood coagulation analyzers look positive, thanks to technological improvements and rising demand for individualized therapy. Point-of-care testing, integration with electronic health records, and home miniaturization are all predicted to improve the ease and accuracy of coagulation tests.

Furthermore, the development of more complex analyzers capable of thorough testing and real-time monitoring is likely to enhance patient outcomes and streamline clinical operations. As the healthcare industry evolves, these analyzers will be critical to the treatment of coagulation diseases and the growth of precision medicine.

Global Blood Coagulation Analyzer Market Dynamics

The key market dynamics that are shaping the global blood coagulation analyzer market include:

Key Market Drivers:

Increasing Prevalence of Blood Disorders:

Blood coagulation analyzers are in high demand due to the increasing prevalence of blood diseases among patients. According to the World Federation of Hemophilia's Annual Global Survey 2019, there were over 324,000 people with hemophilia globally, up 7% over the previous year.

Rising Geriatric Population:

As the world's population ages, there is a greater risk of cardiovascular disease and clotting disorders, increasing the demand for coagulation tests. According to the United Nations' World Population Prospects 2019 report, by 2050, one in every six persons worldwide will be over the age of 65, up from one in every eleven in 2019.

Increasing Surgical Procedures:

Increasing surgical procedures worldwide need more coagulation tests for pre- and post-operative care. According to a report published in The Lancet in 2021, the number of surgical procedures performed worldwide increased by 38.2% between 2008 and 2018, reaching 313 million each year.

Technological Advancements in Coagulation Analyzers:

Technological advances in blood coagulation analyzers, including increased accuracy and faster results, are driving market expansion. According to a 2022 National Institutes of Health (NIH) report, point-of-care coagulation testing equipment can already offer results in as little as 1-3 minutes, compared to typical laboratory procedures that take 30-60 minutes.

Key Challenges:

Technological Complexity:

Blood coagulation analyzers are complex instruments that require advanced technology and precision engineering. It might be difficult to keep up with rapid technological advances while maintaining accuracy and reliability. To remain competitive, manufacturers must consistently innovate and upgrade their systems, which requires major expenditure in R&D.

Data Management:

Modern coagulation analyzers generate a huge amount of data, which must be carefully recorded, stored, and processed. Effective data management systems are essential for ensuring that results are dependable and easily accessible. Integrating these technologies with other hospital information systems can be difficult.

Product Calibration and Maintenance:

Regular calibration and maintenance are required to ensure the accuracy and reliability of coagulation analyzers. This continual necessity can be difficult, particularly for healthcare facilities with limited resources, and may impact the operational efficiency and cost of employing these devices.

High Costs:

Blood coagulation analyzers can be expensive both to purchase and to maintain. This includes the cost of the equipment, consumables, and the necessity for periodic calibration and servicing. These high prices can be prohibitive for smaller clinics and laboratories, restricting access to advanced coagulation diagnostics.

Key Trends:

Point-of-Care Testing:

Point-of-care (POC) testing for blood coagulation is becoming more popular, as it provides quick, on-site results rather than sending samples to a central lab. This trend is motivated by the desire for faster diagnostic results and more patient convenience. POC devices are becoming smaller and more user-friendly, allowing for rapid decision-making in a variety of clinical settings, including emergency rooms and outpatient clinics.

Integration with Electronic Health Records (EHRs):

Blood coagulation analyzers are increasingly being linked to electronic health records (EHRs) to expedite data administration and improve patient care. This interface offers smooth data transfer, real-time access to patient information, and improved coordination among healthcare providers, hence increasing the overall efficiency of coagulation testing and management.

Miniaturization and Portability:

The development of small and portable blood coagulation analyzers is a major trend. These small instruments provide versatility and simplicity, enabling coagulation testing in a variety of contexts, including remote locations and home care settings. Portable analyzers address the growing demand for dispersed testing solutions.

Advanced Technology and Automation:

Blood coagulation analyzers are becoming more useful as a result of advances in automation and technology. Features such as automated sample handling, data processing, and result reporting are becoming increasingly common, enhancing accuracy, eliminating manual errors, and increasing test throughput.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Global Blood Coagulation Analyzer Market Regional Analysis

Here is a more detailed regional analysis of the global blood coagulation analyzer market:

North America:

North America continues to lead the blood coagulation analyzer market due to its excellent healthcare infrastructure, cutting-edge medical research, and the high prevalence of chronic disorders that necessitate regular coagulation monitoring. The region's well-established healthcare system promotes the widespread use of sophisticated diagnostic instruments, such as blood coagulation analyzers. According to the CDC, almost 900,000 Americans suffer from deep vein thrombosis or pulmonary embolism each year, with up to 100,000 deaths attributed to these illnesses. This high incidence highlights the urgent necessity for precise and rapid coagulation testing. The American Heart Association's 2024 update states that cardiovascular disorders affect roughly half of American adults, with many requiring continuing anticoagulant medication, increasing the requirement for dependable coagulation monitoring.

North America's enormous investments in medical technology and research strengthen its market supremacy. According to the National Institutes of Health, the region will account for more than 40% of worldwide healthcare R&D spending in 2023, with a large share going toward diagnostic technology such as blood coagulation analyzers. A growing emphasis on preventive healthcare and early detection is also a crucial driver, as indicated by a 2024 study that predicts an 8.5% annual growth rate in point-of-care coagulation testing across North America. This emphasis on rapid and accessible diagnostic solutions continues to drive market growth, establishing North America's dominant position in the blood coagulation analyzer sector.

Asia Pacific:

The Asia-Pacific area is rapidly emerging as the fastest-growing market for blood coagulation analyzers, owing to several revolutionary forces that are transforming the healthcare environment. Cardiovascular disorders account for 31% of all deaths in the region and about 6.2 million deaths per year, the extreme need for enhanced coagulation monitoring. This high prevalence contributes significantly to the rising demand for blood coagulation analyzers. The region's aging population is driving market growth. The United Nations Economic and Social Commission for Asia and the Pacific predicts that the number of older people in the region will quadruple by 2050, increasing the prevalence of age-related coagulation diseases and driving up the need for monitoring systems.

Rising healthcare expenditure in Asia-Pacific is also driving market expansion. This increased investment promotes the expansion of healthcare infrastructure and the availability of advanced diagnostic technology. Improved access to healthcare services for the region's growing middle class, combined with technology developments and improved awareness of blood problems, is fueling market growth. According to reports, point-of-care coagulation testing equipment use in India is growing at a 12% yearly rate, suggesting a regional trend toward rapid and accessible diagnostic options.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Global Blood Coagulation Analyzer Market: Segmentation Analysis

The Global Blood Coagulation Analyzer Market is Segmented on the basis of Technology, Test Type, Distribution Channel, And Geography.

Blood Coagulation Analyzer Market, By Technology

• Optical Technology
• Mechanical Technology
• Electrochemical Technology

Based on Technology, the market is bifurcated into Optical Technology, Mechanical Technology, and Electrochemical Technology. Optical technology leads the blood coagulation analyzer market due to its great sensitivity, accuracy, and convenience. This method uses light to measure coagulation parameters, providing accurate and consistent results. On the other hand, electrochemical technology is emerging as the fastest-growing segment, given to its potential for downsizing and point-of-care applications. This method uses electrical signals to measure coagulation parameters, allowing for portable and convenient quick testing in a variety of scenarios.

Blood Coagulation Analyzer Market, By Test Type

• APTT
• D-Dimer
• Fibrinogen
• PT

Based on Test Type, the market is segmented into APTT, D-Dimer, Fibrinogen, and PT. The blood coagulation analyzer market is divided into two dominating segments: APTT and PT. APTT assesses the internal process of coagulation, whereas PT evaluates the extrinsic pathway. These tests are commonly used to assess patients with bleeding or clotting issues. D-dimer is a new segment that is quickly gaining popularity due to its significance in identifying deep vein thrombosis (DVT) and pulmonary embolism (PE). The rising prevalence of these disorders, combined with the development of more sensitive D-dimer testing, has accelerated its expansion.

Blood Coagulation Analyzer Market, By Distribution Channel

• Clinical Laboratory
• Point-of-Care (POC)
• Hospitals

Based on Distribution Channel, the market is segmented into Clinical Laboratory, Point-of-Care (POC), and Hospitals. Hospitals dominate the blood coagulation analyzer market due to requiring extensive testing for a diverse spectrum of patients. However, point-of-care (POC) testing is emerging as the most rapidly rising area. POC devices provide fast outcomes at the bedside, allowing for timely decision-making in critical care settings. The growing demand for decentralized testing, combined with technological developments in POC analyzers, is propelling their implementation in a variety of healthcare settings.

Blood Coagulation Analyzer Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the World
• On the basis of Geography, the Global Blood Coagulation Analyzer Market is classified into North America, Europe, Asia Pacific, and the Rest of the World. North America continues to dominate the blood coagulation analyzer market due to its established healthcare infrastructure, advanced medical research, and high prevalence of chronic disorders. However, Asia-Pacific is emerging as the fastest-growing area, owing to reasons such as rising healthcare spending, increased awareness of blood coagulation disorders, and the expansion of healthcare infrastructure.

Key Players

• The "Global Blood Coagulation Analyzer Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are
• Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Sysmex Corporation, Thermo Fisher Scientific, Inc., Maccura Biotechnology Co. Ltd., Diagnostica Stago SAS, and Helena Laboratories.
• The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

• Blood Coagulation Analyzer Market Recent Developments
• In July 2022, HORIBA Medical will release the latest Yumizen G800 and G1550 hemostasis analyzers, as well as a line of handy ready-to-use reagents for common blood coagulation assays. With the growth of its product line, HORIBA Medical now offers a full array of hemostasis systems and innovative reagents to laboratories of all sizes and needs.
• In October 2021, Trivitron Healthcare announced the launch of a new line of Coagulation Analyzer products developed by Diagon Ltd. The newly announced product line includes the COAG Line, which includes automated, semi-automated, and POC systems developed by Diagon Hungary. These cutting-edge technologies are critical in decreasing bleeding risks during extensive procedures, as well as evaluating the efficacy of hemostatic treatments and anticoagulants.
• In October 2021, Trivitron Healthcare, a medical device business, unveiled a new line of Coagulation Analyzer products in India, produced by Diagon Ltd.
• In February 2021, Siemens Healthineers and Sysmex Corporation announced the renewal of their long-standing global supply, distributorship, sales, and service agreement for a broad portfolio of hemostasis devices, which included a multi-year extension.

TABLE OF CONTENTS

1. Introduction

• Market Definition
• Market Segmentation
• Research Methodology

2. Executive Summary

• Key Findings
• Market Overview
• Market Highlights

3. Market Overview

• Market Size and Growth Potential
• Market Trends
• Market Drivers
• Market Restraints
• Market Opportunities
• Porter's Five Forces Analysis

4. Blood Coagulation Analyzer Market, By Type of Analyzer

• Clinical Laboratory Analyzers
• Point-of-Care (POC) Analyzers

5. Blood Coagulation Analyzer Market, By Application

• Routine Coagulation Tests
• Special Coagulation Tests
• Thrombophilia Testing
• Other Applications

6. Blood Coagulation Analyzer Market, By End-User

• Hospitals
• Clinics and Physician Offices
• Diagnostic Centers
• Research Institutes

7. Regional Analysis

• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Italy
• Asia-Pacific
• China
• Japan
• India
• Australia
• Latin America
• Brazil
• Argentina
• Chile
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE

8. Market Dynamics

• Market Drivers
• Market Restraints
• Market Opportunities
• Impact of COVID-19 on the Market

9. Competitive Landscape

• Key Players
• Market Share Analysis

10. Company Profiles

• Abbott Laboratories
• Danaher Corporation
• Siemens Healthineers AG
• Sysmex Corporation
• Thermo Fisher Scientific Inc.
• Maccura Biotechnology Co. Ltd.
• Diagnostica Stago SAS
• Helena Laboratories

11. Market Outlook and Opportunities

• Emerging Technologies
• Future Market Trends
• Investment Opportunities

12. Appendix

• List of Abbreviations
• Sources and References